Evaluating Lynch syndrome in very early onset colorectal cancer probands without apparent polyposis Kory W. JaspersonThuy M. VuJeffrey N. Weitzel OriginalPaper 03 September 2009 Pages: 99 - 107
Recommendations to improve identification of hereditary and familial colorectal cancer in Europe H. F. A. VasenG. MösleinH. Müller OriginalPaper 18 September 2009 Pages: 109 - 115
Mutation analysis of the APC gene in Taiwanese FAP families: low incidence of APC germline mutation in a distinct subgroup of FAP families J. M. ChiangH. W. ChenJ. Y. Wang OriginalPaper 19 September 2009 Pages: 117 - 124
Frequent alterations of the PI3K/AKT/mTOR pathways in hereditary nonpolyposis colorectal cancer Anna Isinger EkstrandMats JönssonMef Nilbert OriginalPaper 03 September 2009 Pages: 125 - 129
Clinical and histomolecular endometrial tumor characterization of patients at-risk for Lynch syndrome in South of Brazil Silvia Liliana CossioPatricia Koehler-SantosJoão Carlos Prolla OriginalPaper 11 October 2009 Pages: 131 - 139
An Ashkenazi founder mutation in the MSH6 gene leading to HNPCC Yael GoldbergRinnat M. PoratTamar Peretz OriginalPaper 23 October 2009 Pages: 141 - 150
Biallelic MYH germline mutations as cause of Muir-Torre syndrome Carmen Guillén-PonceAdela CastillejoJ. L. Soto BriefCommunication 09 December 2009 Pages: 151 - 154
Mismatch repair protein expression and colorectal cancer in Hispanics from Puerto Rico Wilfredo E. De Jesus-MongeCarmen Gonzalez-KeelanMarcia Cruz-Correa OriginalPaper 11 December 2009 Pages: 155 - 166
Selection of patients with germline MLH1 mutated Lynch syndrome by determination of MLH1 methylation and BRAF mutation Hanifa BouzourenePierre HutterJean Benhattar OriginalPaper 01 December 2009 Pages: 167 - 172
Serum antibodies against frameshift peptides in microsatellite unstable colorectal cancer patients with Lynch syndrome Miriam ReuschenbachMatthias KloorMagnus von Knebel Doeberitz OriginalPaper 02 December 2009 Pages: 173 - 179
A PALB2 germline mutation associated with hereditary breast cancer in Italy Laura PapiAnna Laura PutignanoDomenico Palli BriefCommunication 18 September 2009 Pages: 181 - 185
Heterogeneous prevalence of recurrent BRCA1 and BRCA2 mutations in Spain according to the geographical area: implications for genetic testing Orland DiezSara Gutiérrez-EnríquezJudith Balmaña BriefCommunication 26 November 2009 Pages: 187 - 191
Efficiency of BRCAPRO and Myriad II mutation probability thresholds versus cancer history criteria alone for BRCA1/2 mutation detection J. J. T. van HarsselC. E. P. van RoozendaalE. B. Gómez García OriginalPaper Open access 01 December 2009 Pages: 193 - 201
Retrospective comparison of patient outcomes after in-person and telephone results disclosure counseling for BRCA1/2 genetic testing Courtney Doughty RiceJennifer Gamm RuschmanErin Miller OriginalPaper 22 November 2009 Pages: 203 - 212
Female BRCA mutation carriers with a preference for prophylactic mastectomy are more likely to participate an educational-support group and to proceed with the preferred intervention within 2 years Karin M. LandsbergenJudith B. PrinsNicoline Hoogerbrugge OriginalPaper 05 December 2009 Pages: 213 - 220
Outcomes of nasopharyngeal carcinoma screening for high risk family members in Hong Kong Wai Tong NgCheuk Wai ChoiAnne W. M. Lee OriginalPaper 25 September 2009 Pages: 221 - 228
Heredity, diet and lifestyle as determining risk factors for the esophageal cancer on Nanao Island in Southern China Min LiuMin SuYu-Xia Gao OriginalPaper 15 November 2009 Pages: 229 - 238
Hereditary leiomyomatosis and renal cell carcinoma: very early diagnosis of renal cancer in a paediatric patient Ismail AlrashdiSamantha LevineShirley V. Hodgson OriginalPaper 05 December 2009 Pages: 239 - 243
No evidence for a genetic modifier for renal cell cancer risk in HLRCC syndrome Pia VahteristoTaru A. KoskiRainer Lehtonen OriginalPaper 20 December 2009 Pages: 245 - 251
Evolving perspectives on genetic discrimination in health insurance among health care providers Carin R. HuizengaKatrina LowstuterJeffrey N. Weitzel OriginalPaper 05 December 2009 Pages: 253 - 260
Erratum to: FAP-associated desmoid invasiveness correlates with in vitro resistance to doxorubicin David E. JoynerSylvia H. TrangR. L. Randall Erratum 27 November 2009 Pages: 261 - 261
